
HEALTH PROGRAM
"Life in the rhythm of the heart:
microbiome and health
cardiovascular system"
Cardiovascular diseases (CVD) are a group of diseases associated with pathology of the heart or blood vessels.
GROUNDING
The main trigger for most cardiovascular
vascular diseases is atherosclerosis, the development of which
cholesterol deposits (plaques) appear on the walls of blood vessels. Over time, they increase, narrowing the lumen of the vessels. This leads to impaired blood circulation and nutrition of various organs - they do not receive enough oxygen and nutrients. Its danger lies in the long asymptomatic course, during which the disease progresses and provokes the development of other CVDs.

The main diseases of the cardiovascular system include:
✔️ ischemic heart disease - impaired blood supply to the heart muscle due to damage to the heart vessels
✔️ arterial hypertension - an increase in blood pressure, which is based on a disruption in the functioning of the central nervous system and other body systems, which in turn can lead to serious complications such as stroke, heart attack and kidney failure
✔️ congestive heart failure – weakening of the heart muscle, resulting in its inability to pump blood normally
✔️ arrhythmia — abnormal heart rhythm
✔️ cardiomyopathy – loss of the heart muscle's ability to pump blood normally

The program "Life in the Rhythm of the Heart: Microbiome and Cardiovascular Health" is indicated for:

For people who care about their health
in order to exclude and/or timely diagnose atherosclerosis
For persons with disabilities
metabolism
(overweight or underweight, obesity, type 2 diabetes),
atherosclerosis, etc. to prevent the development of CVD
For people with diagnosed
CVS
to prevent progression and
possible complications

KEY INDICATORS
✅ Локальний імунітет
✅ Кишковий мікробіом
✅ Біохімічні показники крові
✅Харчові звички
✅ Фізична активність
CONNECTION BETWEEN THE MICROBIOME
INTESTINAL AND CVD
Recent studies highlight the importance of the gut microbiome as a diagnostic tool.
and therapeutic target for CVD. The gut microbiome regulates human physiological processes,
in particular metabolism.
Changes in the microbiome are associated with the progression of a number of metabolic disorders,
such as overweight, insulin resistance and others.

Most often the cause of such
diseases are our own
behavior and habits, changing
which, we can significantly reduce the risk of CVD.
Встановлено, що А.muciniphila покращує бар’єрну функцію кишечника та володіє протиатеросклеротичною дією. Більш того, у пацієнтів з атеросклерозом спостерігається зменшення кількості Roseburia та
Eubacterium, а також збільшення чисельності Collinsella у порівнянні із здоровими пацієнтами. У пацієнтів з ішемічною хворобою серця відмічають зміни у складі фекальної мікробіоти у бік збільшення чисельності бактерій, які продукують триметиламін (Verrucomicrobiaceae,
Enterobacteriaceae).

COMPOSITION programs:
In-depth study of the intestinal microbiota with identification of commensal beneficial (or useful) and opportunistic pathogens to the species, establishment of a diagnostic
ratio for determining
nosology (condition) of the microbiome
Precise (genetic) analysis of the gut microbiome and metabolomic analysis
Personalized selection
individual nutrition plan
Personalized
selection of pharmabiotics
Personalized selection
other biological products
Personalized selection
biological products
To conduct a survey of the program "Cardiovascular
disease" it is necessary:
Get a special set
for biomaterial collection
Submit, according to the instructions, the biomaterial
for further research
Fill out the author's form online
selection form
personalized nutrition

Керуємо та корегуємо
власний мікробіом з EDIENS!
Scan the QR to learn more about
our products, their proven effectiveness,
to read publications, patents
and scientific research that lies in
the basis of our work!
